-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Summit Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2019 to Q3 2024.
- Summit Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 727M shares, a 4.14% increase year-over-year.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 620M shares, a 221% increase from 2022.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 193M shares, a 46.8% increase from 2021.
- Summit Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 132M shares, a 89.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)